CRL
Charles River Laboratories International, Inc.
Stock
$290.19+3.36 (+1.17%)Close Oct 2, 2026
- Net income, 2025
- −$144M
Net income
Net income by fiscal year
| Period | Net income | YoY |
|---|---|---|
| 2025 | −$144M | — |
| 2024 | $22M | −95.3% |
| 2023 | $475M | −2.4% |
| 2022 | $486M | +24.4% |
| 2021 | $391M | +7.3% |
| 2020 | $364M | +44.6% |
| 2019 | $252M | +11.3% |
| 2018 | $226M | +83.5% |
| 2017 | $123M | −20.3% |
| 2016 | $155M | +3.7% |
| 2015 | $149M | +17.8% |
| 2014 | $127M | +23.2% |
| 2013 | $103M | +5.7% |
| 2012 | $97M | −11.2% |
| 2011 | $110M | — |
| 2010 | −$337M | — |
| 2009 | $114M | — |
| 2008 | −$525M | — |